A novel form of bacterial resistance to the action of eukaryotic host defense peptides, the use of a lipid receptor

Biochemistry

Volumn 52, Issue 35, 2013, Pages 6021-6029

  Dennison, Sarah R ^a   Harris, Frederick ^b   Mura, Manuela ^b   Morton, Leslie H G ^b   Zvelindovsky, Andrei ^b   Phoenix, David A ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM GROUPS; BACTERIAL RESISTANCE; BI-LAYER; CHARGE-CHARGE INTERACTIONS; HOST DEFENSE; N-TERMINALS; PHOSPHOETHANOLAMINE; RESISTANCE MECHANISMS;

COMPUTER SIMULATION; ESCHERICHIA COLI; HYDROGEN BONDS; MEMBRANES;

PEPTIDES;

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; AMMONIA; AMPHOLYTE; ANIONIC SURFACTANT; CALCIMYCIN; LIPID RECEPTOR; LYSOPHOSPHOLIPID RECEPTOR; PEPTIDE; PHOSPHATE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BILAYER MEMBRANE; BINDING AFFINITY; BOMBINA MAXIMA; CHEMICAL INTERACTION; CONTROLLED STUDY; ESCHERICHIA COLI; EUKARYOTE; HOST RESISTANCE; HYDROGEN BOND; HYDROPHOBICITY; LIPID BILAYER; LYSIS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CIRCULAR DICHROISM; DRUG RESISTANCE, MICROBIAL; LIPIDS; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; RECEPTORS, CELL SURFACE;

EID: 84883478501     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi400719j     Document Type: Article

References (51)

1. Davies, J. and Davies, D. (2010) Origins and Evolution of Antibiotic Resistance. Microbiol Mol. Biol. Rev. 74, 417-433
2. Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., and Edwards, J. (2008) The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America Clin. Infect. Dis. 46, 155-164
3. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Jr., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., and Bartlett, J. (2009) Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Clin. Infect. Dis. 48, 1-12
4. Da Silva, G. J. and Mendonca, N. (2012) Association between antimicrobial resistance and virulence in Escherichia coli Virulence 3, 18-28
5. Tadesse, D. A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M. J., and McDermott, P. F. (2012) Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950-2002 Emerg. Infect. Dis. 18, 741-749
6. Cullen, I. M., Manecksha, R. P., McCullagh, E., Ahmad, S., O'Kelly, F., Flynn, R. J., McDermott, T., Murphy, P., Grainger, R., Fennell, J. P., and Thornhill, J. A. (2012) The changing pattern of antimicrobial resistance within 42 033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009 BJU Int. 109, 1198-1206
7. Pitout, J. D. D. (2012) Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance Front microbiol. 3, 1-7
8. Totsika, M., Moriel, D. G., Idris, A., Rogers, B. A., Wurpel, D. J., Phan, M. D., Paterson, D. L., and Schembri, M. A. (2012) Uropathogenic Escherichia coli Mediated Urinary Tract Infection Curr. Drug Targets 13, 1386-1399
9. Malecki, M., Mattner, F., and Schildgen, O. (2012) Short review: molecular diagnosis of Escherichia coli O104:H4 Rev. Med. Microbiol. 23, 14-17
10. Pexara, A., Angelidis, D., and Govaris, A. (2012) Shiga toxin-producing Escherichia coli (STEC) food-borne outbreaks J. Hellenic. Vet. Med. Soc. 63, 45-53
11. von Baum, H. and Marre, R. (2005) Antimicrobial resistance of Escherichia coli and therapeutic implications Int. J. Med. Microbiol. 295, 503-511
12. Cars, O., Hedin, A., and Heddini, A. (2011) The global need for effective antibiotics-Moving towards concerted action Drug Resist. Updat. 14, 68-69
13. Harris, F. and Pierpoint, L. (2012) Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial Agent Med. Res. Rev. 32, 1292-1327
14. Lloyd, D. H. (2012) Alternatives to conventional antimicrobial drugs: a review of future prospects Vet. Dermatol. 23 (299-304) e259-260
15. Pasupuleti, M., Schmidtchen, A., and Malmsten, M. (2012) Antimicrobial peptides: key components of the innate immune system Crit. Rev. Biotechnol. 32, 143-171
16. Harris, F., Dennison, S. R., and Phoenix, D. A. (2009) Anionic Antimicrobial Peptides from Eukaryotic Organisms Curr. Protein Pept. Sci. 10, 585-606
17. Harris, F., Dennison, S. R., and Phoenix, D. A. (2011) Anionic Antimicrobial Peptides from Eukaryotic Organisms and their Mechanisms of Action Curr. Chem. Biol. 5, 142-153
18. Yount, N. Y. and Yeaman, M. R. (2012) Emerging Themes and Therapeutic Prospects for Anti-Infective Peptides Annu. Rev. Pharmacol. Toxicol. 52, 337-360
19. Dennison, S. R., Wallace, J., Harris, F., and Phoenix, D. A. (2005) Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships Protein Pept. Lett. 12, 31-39
20. Koprivnjak, T. and Peschel, A. (2011) Bacterial resistance mechanisms against host defense peptides Cell. Mol. Life Sci. 68, 2243-2254
21. Gruenheid, S. and Le Moual, H. (2012) Resistance to antimicrobial peptides in Gram-negative bacteria FEMS Microbiol. Lett. 330, 81-89
22. Maria-Neto, S., Candido, E. d. S., Rodrigues, D. R., de Sousa, D. A., da Silva, E. M., Pepe de Moraes, L. M., de Jesus Otero-Gonzalez, A., Magalhaes, B. S., Dias, S. C., and Franco, O. L. (2012) Deciphering the Magainin Resistance Process of Escherichia coli Strains in Light of the Cytosolic Proteome Antimicrob. Agents Chemother. 56, 1714-1724
23. Kai-Larsen, Y., Lüthje, P., Chromek, M., Peters, V., Wang, X., Holm, Å., Kádas, L., Hedlund, K.-O., Johansson, J., Chapman, M. R., Jacobson, S. H., Römling, U., Agerberth, B., and Brauner, A. (2010) Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37 PLoS Pathog. 6, e1001010
24. Radhouani, H., Pinto, L., Poeta, P., and Igrejas, G. (2012) After genomics, what proteomics tools could help us understand the antimicrobial resistance of Escherichia coli ? J. Proteomics 75, 2773-2789
25. Lohner, K. and Prenner, E. J. (1999) Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems Biochim. Biophys. Acta 1462, 141-156
26. Phoenix, D. A., Dennison, S. R., and Harris, F. (2013) Models for the membrane interactions of antimicrobial peptides. in Antimicrobial peptides (Phoenix, D. A., Dennison, S. R., and Harris, F. Eds.) pp 145-180, Wiley, Germany.
27. Liu, R., Liu, H., Ma, Y., Wu, J., Yang, H., Ye, H., and Lai, R. (2011) There are Abundant Antimicrobial Peptides in Brains of Two Kinds of Bombina Toads J. Proteome Res. 10, 1806-1815
28. Lai, R., Liu, H., Lee, W. H., and Zhang, Y. (2002) An anionic antimicrobial peptide from toad Bombina maxima Biochem. Biophys. Res. Commun. 295, 796-799
29. AMBER (2010) http:/ambermd.org.
30. Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008) GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation J. Chem. Theory Comput. 4, 435-447
31. Lumb, C. N., He, J., Xue, Y., Stansfeld, P. J., Stahelin, R. V., Kutateladze, T. G., and Sansom, M. S. (2011) Biophysical and computational studies of membrane penetration by the GRP1 pleckstrin homology domain Structure 19, 1338-1346
32. Wall, J., Golding, C. A., Van Veen, M., and O'Shea, P. (1995) The use of fluoresceinphosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane interactions Mol. Membr. Biol. 12, 183-192
33. Dennison, S. R., Morton, L. H. G., and Phoenix, D. A. (2012) Role of molecular architecture on the relative efficacy of aurein 2.5 and modelin 5 Biochim. Biophys. Acta 1818, 2094-2102
34. Whitmore, L. and Wallace, B. A. (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32, W668-W673
35. Whitmore, L. and Wallace, B. A. (2008) Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databases Biopolymers 89, 392-400
36. Zhao, M. (2011) Lantibiotics as probes for phosphatidylethanolamine Amino Acids 41, 1071-1079
37. Harris, F., Dennison, S. R., and Phoenix, D. A. (2012) Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders? FASEB J. 26, 1776-1781
38. Phoenix, D. A., Dennison, S. R., and Harris, F. (2013) Anionic Antimicrobial Peptides, in Antimicrobial Peptides (Phoenix, D. A., Dennison, S. R., and Harris, F., Eds.) pp 83-113, Wiley, Germany.
39. Henriques, S. T., Huang, Y.-H., Rosengren, K. J., Franquelim, H. G., Carvalho, F. A., Johnson, A., Sonza, S., Tachedjian, G., Castanho, M. A. R. B., Daly, N. L., and Craik, D. J. (2011) Decoding the Membrane Activity of the Cyclotide Kalata B1. The Importance of Phosphatidiletanolamine Phospholipids and Lipid Organization on Hemolytic and anti-HIV Activities J. Biol. Chem. 286, 24231-24241
40. Burman, R., Strömstedt, A. A., Malmsten, M., and Göransson, U. (2011) Cyclotide-membrane interactions: Defining factors of membrane binding, depletion and disruption Biochim. Biophys. Acta 1808, 2665-2673
41. Prabhu, S., Dennison, S., Lea, B., Snape, T., Nicholl, I., Radek, I., and Harris, F. (2013) Anionic antimicrobial and anticancer peptides from plants Crit. Rev. Plant Sci. 32, 303-320
42. Henriques, S. T., Huang, Y.-H., Castanho, M. A. R. B., Bagatolli, L. A., Sonza, S., Tachedjian, G., Daly, N. L., and Craik, D. J. (2012) Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions J. Biol. Chem. 287, 33629-33643
43. Pranting, M., Loov, C., Burman, R., Goransson, U., and Andersson, D. I. (2010) The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria J. Antimicrob. Chemother. 65, 1964-1971
44. Sohlenkamp, C., López-Lara, I. M., and Geiger, O. (2003) Biosynthesis of phosphatidylcholine in bacteria Prog. Lipid Res. 42, 115-162
45. Phoenix, D. A., Dennison, S. R., and Harris, F. (2013) Cationic antimicrobial peptides and their structure/function relationships, in Antimicrobial Peptides (Phoenix, D. A., Dennison, S. R., and Harris, F., Eds.) pp 39-81, Wiley, Germany.
46. Madrid, E. and Horswell, S. L. (2013) Effect of headgroup on the physicochemical properties of phospholipid bilayers in electric fields: size matters Langmuir 29, 1695-1708
47. Cheng, J. T., Hale, J. D., Elliott, M., Hancock, R. E., and Straus, S. K. (2011) The importance of bacterial membrane composition in the structure and function of aurein 2.2 and selected variants Biochim. Biophys. Acta 1808, 622-633
48. Murzyn, K., Rog, T., and Pasenkiewicz-Gierula, M. (2005) Phosphatidylethanolamine-phosphatidylglycerol bilayer as a model of the inner bacterial membrane Biophys. J. 88, 1091-1103
49. Wang, G. S., Watson, K. M., Peterkofsky, A., and Buckheit, R. W. (2010) Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide Database Antimicrob. Agents Chemother. 54, 1343-1346
50. Dennison, S. R., Morton, L. H., Brandenburg, K., Harris, F., and Phoenix, D. A. (2006) Investigations into the ability of an oblique alpha-helical template to provide the basis for design of an antimicrobial anionic amphiphilic peptide FEBS J. 273, 3792-3803
51. Afacan, N. J., Yeung, A. T. Y., Pena, O. M., and Hancock, R. E. W. (2012) Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections Curr. Pharm. Des. 18, 807-819